Document:

<PAGE>

                                                                   EXHIBIT 10.23

                              EMPLOYMENT AGREEMENT

      This EMPLOYMENT AGREEMENT (this "Agreement") is made and entered into as
of September 15, 2003 by and among WellCare Health Plans, Inc., a Delaware
corporation ("WellCare"), Comprehensive Health Management, Inc., a Florida
corporation and a wholly-owned subsidiary of WellCare (the "Company"), and Paul
Behrens, an individual (the "Executive"). The Executive, WellCare and the
Company may sometimes hereinafter be referred to individually as a "party" or
jointly as the "parties."

      WHEREAS, the parties wish to enter into an employment agreement to employ
the Executive and to set forth certain terms and conditions of employment
between the Executive and the Company, as set forth in this Agreement.

      NOW, THEREFORE, in consideration of the covenants, promises,
representations and warranties set forth herein, and for other good and valuable
consideration (the receipt and sufficiency of which are hereby acknowledged by
the parties), intending to be legally bound hereby, the parties agree as
follows:

      1.    Term. The Company shall employ the Executive, and the Executive
shall serve the Company, subject to the terms and conditions of this Agreement,
for an initial term (the "Term") of three years, commencing on September 15,
2003 (the "Effective Date"). Effective as of the expiration of such initial
three-year Term and as of each annual anniversary date thereof, the Term shall
be extended for an additional one-year period unless, not later than three
months prior to such respective date, either party shall have given notice to
the other that the Term shall not be so extended (a "Notice of Non-Renewal").
Notwithstanding the foregoing, the Executive's employment by the Company may be
terminated prior to the completion of the then Term, as provided in Section 4
hereof. The period of time beginning on the Effective Date and ending on the
first to occur of (a) the last day of the Term and (b) the date the Executive
ceases to be a full-time employee of the Company for any reason shall be
referred to herein as the "Employment Period." In the event a Notice of
Non-Renewal is delivered by either party as provided above, then, as of the end
of the Term, unless the Executive is no longer an employee of the Company as of
such time, the Executive shall become an at-will employee of the Company.

      2.    Employment.

            (a) Positions and Reporting. The Company hereby employs the
Executive for the Employment Period as its Senior Vice President and Chief
Financial Officer and on the terms and conditions set forth in this Agreement.
During the Employment Period, the Executive shall also serve in such executive
capacity and with the responsibility and duties set forth herein (i) on behalf
of each of the direct or indirect wholly owned subsidiaries of WellCare and (ii)
so long as it owns all of WellCare's issued and outstanding shares of common
stock, on behalf of WellCare Holdings, LLC, a Delaware limited liability company
("Holdings"), which as of the date hereof is the parent entity of WellCare.
During the Employment Period, the Executive shall report directly to and shall
be subject to the authority of (i) the Chief Executive Officer of Holdings, or,
if Holdings ceases to own all of WellCare's issued and outstanding shares of
common stock, then

<PAGE>

to the Chief Executive Officer of WellCare (in either case, the "Chief
Executive Officer"), or (ii) at the option of the Company, to any person
reporting directly to the Chief Executive Officer.

            (b) Authority and Duties. The Executive shall exercise such
authority, perform such duties and functions and discharge such responsibilities
as are reasonably associated with and required by the Executive's position,
commensurate with the authority vested in the Executive pursuant to this
Agreement. During the Employment Period, the Executive shall devote his full
business time, skill and efforts to the business and affairs of Holdings,
WellCare and their respective direct and indirect subsidiaries (including the
Company) whether currently existing or hereafter acquired or formed
(collectively, the "WellCare Group"). Executive shall perform such duties,
functions and responsibilities to the best of Executive's abilities in a
diligent, trustworthy, businesslike and efficient manner.

      3.    Compensation and Benefits.

            (a) Salary. During the Employment Period, the Company shall pay to
the Executive, as compensation for the performance of the Executive's duties and
obligations under this Agreement, a base salary equal to $275,000 per year (the
"Base Salary"). Such Base Salary will be payable in arrears not less frequently
than monthly in accordance with the normal payroll practices of the Company.

            (b) Signing Bonus. The Company shall pay to the Executive, within
ten days following the Effective Date, a signing bonus in the amount of $75,000
(the "Signing Bonus").

            (c) Annual Bonus. The Executive shall be eligible to participate in
any bonus compensation program that may be established by the Board of Directors
of Holdings or, if Holdings ceases to own all of WellCare's issued and
outstanding shares of common stock, then the Board of Directors of WellCare (in
either case, the "Board") for the benefit of senior executives of the WellCare
Group. Any such bonus compensation shall be payable in the form of cash or
equity of Holdings, to be paid by the Company within 30 days after the receipt
and approval by the Board of the WellCare Group's audited fiscal year-end
financial statements. The Executive's initial annual bonus potential shall be
50% of the Base Salary. The determination of the bonus amount for any such
fiscal year (or part thereof) shall be based upon the satisfaction of
performance criteria for such fiscal year that will be established by the
compensation committee of the Board (the "Compensation Committee") (or the full
Board, if no such committee shall exist) in its discretion and upon consultation
with the Chief Executive Officer by no later than the earlier of 90 days after
the Board has approved the WellCare Group's budget for such fiscal year or the
end of the first fiscal quarter of such fiscal year. Such performance criteria
will include corporate performance goals consistent with the WellCare Group's
business plan and budget for such fiscal year, as well as individual objectives
for the Executive's performance that are separate from, but are consistent with,
such WellCare Group's business plan and budget. The final determinations as to
the actual corporate and individual performance against the pre-established
goals and objectives, and the amounts of the bonus payout in relationship to
such performance, shall be made by the Compensation Committee (or Board, as
applicable) in its sole discretion, based on the input and recommendations of
the Chief Executive Officer. The Executive shall be eligible to participate in
any bonus compensation program pursuant to this Section 3(c) for the fiscal year
ending December 31, 2003 on the same basis as other senior

                                        2

<PAGE>

executives of the WellCare Group, as though the Executive had been employed by
the Company beginning on the first day of such fiscal year.

            (d) Equity Distribution. Subject to Board approval, the Executive
will be granted 563,945.6 Class C Common Units of Holdings, representing 1.75%
of the outstanding equity securities of Holdings, calculated on a fully-diluted
basis. This grant will vest 25% on the first anniversary of the date of grant,
and in 36 equal monthly installments thereafter, subject to accelerated vesting
in full in the event of the termination of the Executive's employment by the
Company without Cause, or by the Executive for Good Reason, following a change
of control of the WellCare Group. As a condition to the receipt of this equity
grant, the Executive will be required to purchase Class A Common Units of
Holdings at the current fair market value of $3.00 per Unit, which Units have a
liquidation preference and an 8% annual return, and to become a party to
Holdings' Limited Liability Company Agreement. Such grant and purchase will be
subject to the terms and conditions of Holdings' 2002 Senior Executive Equity
Plan and Holdings' standard form of Subscription Agreement under such Plan

            (e) Insurance Policies. The Company shall purchase, for up to an
annual premium amount of $3,000, and maintain in force during the Employment
Period, life and disability insurance on the Executive, the beneficiary of which
shall be designated by the Executive (the "Executive Policies"). In the event
that the Company cancels the Executive Policies (whether or not in breach of
this Agreement), the Executive shall have the option to continue them in force
at his own expense. Subject to insurability, the Executive Policies shall be
assigned to the Executive upon the termination of Executive's employment with
the Company.

            (f) Other Benefits. During the Employment Period, the Executive
shall receive such other pension, health insurance, holiday, vacation and sick
pay benefits and other employee benefits (including participation in any
deferred compensation or other incentive plans) which the Company extends, as a
matter of policy, to its executive employees. Without limiting the generality of
the foregoing, the Executive shall be entitled to three weeks of vacation during
each full calendar year of the Employment Period, which vacation benefits shall
be appropriately pro rated for any partial calendar year during the Employment
Period; provided, however, that the Executive shall be entitled to three full
weeks of vacation during the remainder of calendar year 2003. All vacation shall
be scheduled in the Executive's discretion, but subject to consultation with the
Chief Executive Officer, subject to and taking into account the business
exigencies of the WellCare Group.

            (g) Business Expenses. During the Employment Period, the Company
shall promptly reimburse the Executive for all documented reasonable business
expenses incurred by the Executive in the performance of the Executive's duties
under this Agreement, in accordance with the Company's standard policies and
practices.

            (h) Relocation. As part of his duties under this Agreement, the
Executive agrees to relocate his principal residence to a location near Tampa,
Florida, the Company's principal place of business, by no later than the
mid-year holiday break at his children's school during the 2003-2004 school year
(i.e., occurring in December 2003 and January 2004). In order to compensate the
Executive for the expenses incurred in connection with such relocation, the

                                        3

<PAGE>

Company shall reimburse the Executive for up to $25,000 of documented,
reasonable costs and expenses incurred by the Executive in connection with such
relocation (all such costs and expenses reimbursed by the Company, collectively,
the "Relocation Expenses").

      4.    Termination Of Employment. This Agreement and the Executive's
employment with the Company may be terminated prior to the expiration of the
Term in any of the following ways:

            (a) Termination Upon Death or Disability. The Employment Period
shall be terminated by the death of the Executive. In the event of the
Disability (as defined below) of the Executive during the Employment Period, the
Company shall have the right to terminate the Employment Period by giving
30-days' advance written notice to that effect to the Executive. For purposes of
this Agreement, the term "Disability" means any disability as defined under the
Company's applicable disability insurance policy or, if no such policy is
available, any physical or mental disability or incapacity that renders the
Executive incapable of performing the essential functions required of the
Executive in accordance with the obligations under Section 2 hereof for a period
of three consecutive months or for shorter periods aggregating to 120 days
(whether or not consecutive) during any consecutive 12-months of the Employment
Period. In the event of any disagreement between the Company and the Executive
as to the Disability of the Executive, such determination shall be made by a
qualified physician to be selected by the Company and reasonably acceptable to
the Executive. The Executive shall be available for examination by such
physician at any reasonable time or times. If the Executive does not cooperate
in such examination(s), then the determination of the Executive's Disability or
non-disability shall be made by the Company in its sole discretion.

            (b) Termination for Cause. Prior to the expiration of the Term, the
Company, effective upon the date specified in the notice of such termination,
may terminate the Executive's employment with the Company for Cause (as defined
below). For purposes of this Agreement and subject to the Executive's
opportunity to cure as provided in Section 4(e) hereof, the Company shall have
"Cause" to terminate the Executive's employment hereunder if the Executive shall
commit any of the following:

                  (i) any act or omission, other than as a result of the
Executive's Disability, which shall represent a willful breach of any of the
material terms of this Agreement;

                  (ii) wanton and reckless acts or omissions in the performance
of the Executive's duties, other than as a result of the Executive's Disability,
in any such case which are to the material detriment of the WellCare Group;

                  (iii) bad faith in the performance of the Executive's duties,
consisting of willful acts or omissions, other than as a result of the
Executive's Disability, to the material detriment of the WellCare Group; or

                  (iv) any conviction or pleading of guilty or nolo contendre to
a crime that constitutes a felony or that involves financial misconduct under
the laws of the United States or any political subdivision thereof.

                                        4

<PAGE>

            (c) Termination Without Cause. Prior to the expiration of the Term,
the Company, effective upon the date specified in the notice of such
termination, may terminate this Agreement and the Executive's employment by the
Company for any reason whatsoever. Prior to the expiration of the Term, the
termination of the Executive's employment by the Company for any reason other
than Cause, Disability or death shall constitute a termination "Without Cause"
hereunder.

            (d) Termination by Executive. The Executive, upon 30 days' prior
written notice given to the Company, shall have the right at any time to
terminate the Executive's employment with the Company for any reason. Prior to
the expiration of the Term, the termination by the Executive of the Executive's
employment with the Company for any reason other than for Good Reason (as
defined below) or death shall constitute a "Voluntary Resignation" hereunder.
For purposes of this Agreement and subject to the Company's opportunity to cure
as provided in Section 4(e) hereof, the Executive shall have "Good Reason" to
terminate employment hereunder if such termination shall be the result of:

                  (i) a failure of the Company to pay the compensation and
benefits set forth in Section 3 hereof;

                  (ii) any act or omission by the Company which shall represent
a willful breach of any of the material terms of this Agreement; or

                  (iii) a material diminution in the duties, authority,
responsibilities or reporting relationship of the Executive in a manner
inconsistent with the Executive's position as set forth in Section 2 hereof.

            (e) Notice and Opportunity to Cure. Notwithstanding the foregoing,
prior to the expiration of the Term, it shall be a condition precedent to the
Company's right to terminate the Executive's employment for Cause and the
Executive's right to terminate employment for Good Reason that (i) the party
seeking the termination shall first have given the other party written notice
stating with specificity the reason for the termination (the "breach") and (ii)
if such breach is susceptible of cure or remedy, a period of 30 days from and
after the giving of such notice shall have elapsed without the breaching party
having effectively cured or remedied such breach during such 30-day period,
unless such breach cannot be cured or remedied within 30 days, in which case the
period for remedy or cure shall be extended for a reasonable time (not to exceed
an additional 30 days) provided the breaching party has made and continues to
make a diligent effort to effect such remedy or cure.

      5.    Consequences of Termination Prior to the Expiration of the Term.

            (a) Termination Without Cause or for Good Reason. In the event of
termination of the Executive's employment with the Company, either by the
Company Without Cause or by the Executive for Good Reason, in each case, prior
to the expiration of the Term, (i) the Company shall continue to pay the
Executive the Base Salary for a period of 12 months (the "Separation Period")
following the effective date of such termination, and (ii) the Company shall
continue during the Separation Period, at the Company's expense, coverage for
the Executive (and his beneficiaries) under the group medical care, disability
and life insurance benefit plans or

                                        5

<PAGE>

arrangements in which the Executive is participating at the time of termination,
including, without limitation, the Executive Policies (or, if such coverage is
precluded by the terms of the Company's insurance policies, the Company shall
make a cash payment to the Executive in an amount sufficient to allow the
Executive to obtain comparable benefits for such period); provided, however,
that the Company's obligation to provide such coverage shall be terminated if
the Executive obtains comparable substitute coverage from another employer at
any time during the Separation Period.

            (b) Termination Upon Disability. In the event of termination of the
Executive's employment hereunder by the Company on account of Disability prior
to the expiration of the Term, (i) the Company shall continue to pay the
Executive's Base Salary as in effect immediately prior to such termination for
the shorter of (x) six months following the first date of Disability and (y) the
then-remainder of the Term, and (ii) the Company shall continue for six months,
at the Company's expense, coverage for the Executive (and his beneficiaries)
under the group medical care, disability and life insurance benefit plans or
arrangements in which the Executive is participating at the time of termination,
including, without limitation, the Executive Policies (or, if such coverage is
precluded by the terms of the Company's insurance policies, the Company shall
make a cash payment to the Executive in an amount sufficient to allow the
Executive to obtain comparable benefits for such period); provided, however,
that the Company's obligation to provide such coverage shall be terminated if
the Executive obtains comparable substitute coverage from another employer at
any time during such continuation period.

            (c) Termination Upon Death. In the event of termination of the
Executive's employment with the Company prior to the expiration of the Term on
account of the Executive's death, (i) the Company shall pay to the Executive's
heirs, estate or personal representatives under law, as applicable, a lump sum
cash payment equal to six months of the Executive's Base Salary and (ii) the
Company shall continue for six months, at the Company's expense, coverage for
the Executive's beneficiaries under the group medical care, disability and life
insurance benefit plans or arrangements in which the Executive was participating
at the time of death, including, without limitation, the Executive Policies (or,
if such coverage is precluded by the terms of the Company's insurance policies,
the Company shall make a cash payment to the Executive's heirs, estate or
personal representatives in an amount sufficient to allow the Executive's
beneficiaries to obtain comparable benefits for such period). The Executive's
beneficiary or estate shall not be required to remit to the Company any payments
received pursuant to any Executive Policies.

            (d) Voluntary Resignation by Executive or Termination With Cause. In
the event of the termination of the Executive's employment hereunder by the
Company for Cause or by Voluntary Resignation by Executive, in each case, prior
to the expiration of the Term, the Company shall have no responsibility or
obligation to make any payments or provide any benefits to the Executive except
to the extent provided in Section 5(e) hereof. Furthermore, in the event of such
termination during the first twelve months of the Term (the "Reimbursement
Period"), the Executive shall be obligated to repay to the Company a pro-rated
portion of the Signing Bonus and the Relocation Expenses, based upon the number
of months of the Reimbursement Period remaining as of the date of such
termination of employment. By way of example, in the event of such termination
after three and one-half months of employment, eight months of the Reimbursement
Period would remain, and the Executive would therefore be

                                        6

<PAGE>

obligated to repay an amount equal to 8/12ths of the Signing Bonus and the
Relocation Expenses. The Executive hereby expressly authorizes the Company, at
any time following the date that the Executive provides notice of his Voluntary
Resignation or the Company provides notice of the termination of the Executive's
employment for Cause, to deduct from any amounts owed to the Executive,
including any payments of salary or expenses, any amount payable by the
Executive pursuant to this Section 5(d). In the event that the Company fails to
so deduct any such amount, or such deductions are insufficient to reimburse the
Company for the total amount payable by the Executive pursuant to this Section
5(d), the Executive shall repay the remaining amount owed promptly upon the
Company's written demand for payment. If the Executive fails to repay such
amount after such written demand, the Executive shall reimburse the Company for
all reasonable costs and expenses incurred by the Company to collect such amount
from the Executive, including court costs and reasonable attorneys' fees.

            (e) Accrued Rights. Notwithstanding the foregoing provisions of this
Section 5, in the event of termination of the Executive's employment hereunder
for any reason, the Company shall pay to or on behalf of the Executive all
unpaid Base Salary accrued through the effective date of termination and a lump
sum cash payment for all unused vacation accrued by the Executive through the
effective date of termination, and the Company shall provide to or on behalf of
the Executive all payments and other benefits accrued for the Executive through
the effective date of termination under all equity arrangements, benefit plans,
programs and arrangements in which the Executive participated during the
Employment Period.

            (f) No Other Payment Obligations. Except as expressly provided for
in Sections 5(a) through 5(e) above or as required by law, upon the date the
Executive ceases to be employed by the Company (i) all of the Executive's rights
to salary, bonus and other benefits hereunder shall cease and (ii) no other
severance or other compensation or benefits shall be payable by any member of
the WellCare Group to the Executive.

            (g) Conditions to Separation of Employment Benefits. The Company
shall have the right to seek repayment of any separation payments and benefits
provided by this Section 5 in the event that the Executive fails to honor in
accordance with their terms the provisions of Sections 6, 7 and 8 hereof. In
addition, the Company may require, as a condition of providing any separation
benefits to the Executive, that the Executive execute a mutually acceptable
release of the Company that shall be negotiated in good faith by both parties.

      6.    Confidential Information.

            (a) The Executive acknowledges that, by reason of the Executive's
employment by the Company, the Executive will have access to confidential
information of the WellCare Group, including, without limitation, information
and knowledge pertaining to products, services, benefits, policies, inventions,
discoveries, improvements, innovations, designs, ideas, trade secrets,
proprietary information, advertising, marketing, distribution and sales methods,
sales and profit figures, provider, customer and client lists and relationships
between the WellCare Group and providers, regulators, sales representatives,
distributors, customers, clients, providers, suppliers and others who have
business dealings with them (collectively, "Confidential Information"). The
Executive acknowledges that such Confidential Information is a valuable and
unique asset of the WellCare Group and covenants that, both

                                        7

<PAGE>

during and after the Employment Period, the Executive will not disclose any
Confidential Information to any third party (except as the Executive's duties as
an employee of the Company may require) without the prior written authorization
of the Chief Executive Officer. The obligation of confidentiality imposed by
this Section 6 shall not apply to Confidential Information that otherwise
becomes generally known to the public through no act of the Executive in breach
of this Agreement or which is required to be disclosed by court order,
applicable law or regulatory requirements.

            (b) All records, designs, business plans, financial statements,
customer lists, manuals, memoranda, lists, research and development plans,
Intellectual Property (as defined below) and other property delivered to or
compiled by the Executive by or on behalf of the WellCare Group or its
providers, clients or customers that pertain to the business of the WellCare
Group shall be and remain the property of the WellCare Group and be subject at
all times to its discretion and control. Likewise, all correspondence, reports,
records, charts, advertising materials and other similar data pertaining to the
business, activities, research and development, Intellectual Property or future
plans of the WellCare Group that is collected by the Executive shall be
delivered promptly to the Company without request by it upon termination of the
Executive's employment. For purposes of this Agreement, "Intellectual Property"
shall mean patents, copyrights, trademarks, trade dress, trade secrets, other
such rights, and any applications.

      7.    Inventions.

      The Executive is hereby retained in a capacity such that the Executive's
responsibilities may include the making of technical and managerial
contributions of value to the WellCare Group. The Executive hereby assigns to
the applicable member of the WellCare Group all rights, title and interest in
such contributions and inventions made or conceived by the Executive alone or
jointly with others during the Employment Period which relate to the business of
the WellCare Group. This assignment shall include (a) the right to file and
prosecute patent applications on such inventions in any and all countries, (b)
the patent applications filed and patents issuing thereon, and (c) the right to
obtain copyright, trademark or trade name protection for any such work product.
The Executive shall promptly and fully disclose all such contributions and
inventions to the Company and assist the Company or any other member of the
WellCare Group, as the case may be, in obtaining and protecting the rights
therein (including patents thereon), in any and all countries; provided,
however, that said contributions and inventions will be the property of the
applicable member of the WellCare Group, whether or not patented or registered
for copyright, trademark or trade name protection, as the case may be.
Notwithstanding the foregoing, no member of the WellCare Group shall not have
any right, title or interest in any work product or copyrightable work developed
outside of work hours and without the use of any of the WellCare Group's
resources that does not relate to the business of the WellCare Group and does
not result from any work performed by the Executive for the WellCare Group.

      8.    Unfair Competition.

            (a) Scope of Covenant. The Executive agrees that during the
Employment Period, and for a period of 12 months after the expiration of the
Employment Period, the Executive shall not, directly or indirectly, for the
Executive or on behalf of or in conjunction

                                        8

<PAGE>

with any other person, company, partnership, business, group, venturer or other
entity (each, a "Person"), without the prior written consent of the Company:

                  (i) engage as an officer, director, shareholder, owner,
partner, joint venturer, or in any managerial capacity, whether as an employee,
independent contractor, consultant or advisor (paid or unpaid), or as a sales
representative, or otherwise participate, in each case, in any business that
sells, markets or provides, anywhere within the United States of America (the
"Territory"), any benefits or services that are in direct competition with the
benefits or services provided by any member of the WellCare Group;

                  (ii) recruit, hire or solicit any employee or former employee
of the WellCare Group or encourage any such employee to leave employment by the
WellCare Group, unless such former employee has not been employed by the
WellCare Group for a period in excess of six months;

                  (iii) call upon any Person who is at the time Executive ceases
to be employed by the Company, or who was at any time during the one year period
prior to the date the Executive ceases to be employed by the Company, a
provider, customer or agent of any member of the WellCare Group for the purpose
of soliciting or selling benefits or services in competition with any member of
the WellCare Group within the Territory; or

                  (iv) request or advise any provider, customer or agent of any
member of the WellCare Group to withdraw, curtail or cancel its business
dealings with the WellCare Group;

provided, however, that nothing in this Section 8(a) shall be construed to
preclude the Executive from making any investment in the securities of any
business enterprise whether or not engaged in competition with any member of the
WellCare Group, to the extent that such securities are actively traded on a
national securities exchange or in the over-the-counter market in the United
States or on any foreign securities exchange, but only if such investment does
not exceed 2% of the outstanding voting securities of such enterprise, provided
that such permitted activity shall not relieve the Executive from any other
provisions of this Agreement.

                  (b) Reasonableness. It is agreed by the parties that the
foregoing covenants in this Section 8 impose a reasonable restraint on the
Executive in light of the activities and business of the WellCare Group on the
date of the execution of this Agreement and the current plans of the WellCare
Group. The Executive acknowledges that the covenants in this Section 8 shall not
prevent the Executive from earning a livelihood upon the termination of
employment hereunder, but merely prevents unfair competition with the WellCare
Group for a limited period of time. Notwithstanding the foregoing, it is the
intent of the Company and the Executive that such covenants be construed and
enforced in accordance with the changing activities, business and locations of
the WellCare Group throughout the term of this covenant.

                  (c) Severability. The covenants in this Section 8 are
severable and separate, and the unenforceability of any specific covenant shall
not affect the provisions of any other covenant. In the event any court of
competent jurisdiction shall determine that the scope, time or territorial
restrictions set forth herein are unreasonable, then it is the intention of the
parties that

                                        9

<PAGE>

such restrictions be enforced to the fullest extent that such court deems
reasonable, and this Agreement shall thereby be reformed.

                  (d) Enforcement by the Company not Limited. All of the
covenants in this Section 8 shall be construed as an agreement independent of
any other provision in this Agreement, and the existence of any claim or cause
of action of the Executive against any member of the WellCare Group, whether
predicated in this Agreement or otherwise, shall not constitute a defense to the
enforcement by the Company of such covenants.

      9.    Breach of Restrictive Covenants. The parties agree that a breach or
violation of Sections 6, 7 or 8 hereof will result in immediate and irreparable
injury and harm to the innocent party, and that such innocent party shall have,
in addition to any and all remedies of law and other consequences under this
Agreement, the right to seek an injunction, specific performance or other
equitable relief to prevent the violation of the obligations hereunder.

      10.   Withholding of Taxes. All payments required to be made by the
Company to the Executive under this Agreement shall be subject to the
withholding of such amounts, if any, relating to tax, and other payroll
deductions as the Company may reasonably determine it should withhold pursuant
to any applicable law or regulation.

      11.   Representations and Warranties. The Executive represents and
warrants that the Executive is entering into this Agreement voluntarily and that
the Executive's employment hereunder and compliance with the terms and
conditions of this Agreement will not conflict with or result in the breach of
any agreement to which the Executive is a party or by which the Executive may be
bound, or any legal duty owed by the Executive to another.

      12.   Director and Officer Insurance. During the Employment Period, the
Company shall use its best efforts to obtain and maintain director's and
officer's insurance for the Executive (in such amounts as are appropriate for
businesses comparable to that of the Company).

      13.   Indemnification. The Company shall indemnify the Executive, in his
capacity as an officer of the Company and any member of the WellCare Group, to
fullest extent permitted under the By-Laws of the Company or such member of the
WellCare Group and applicable law.

      14.   Notices. All notices, requests and other communications hereunder
must be in writing and will be deemed to have been duly given only if delivered
personally against written receipt, or by facsimile transmission against
facsimile confirmation, or by email against confirmation of receipt (but only if
a copy if also sent by first class United States mail (postage prepaid) on the
same day or on the next business day), or mailed by internationally recognized
overnight courier prepaid, to the parties at the following addresses or
facsimile numbers:

                                       10

<PAGE>

                  If to the Company to:

                              Comprehensive Health Management, Inc.
                              6800 North Dale Mabry Highway
                              Suite 268
                              Tampa, FL  33614
                              Attn:  Todd S. Farha
                              Facsimile No.: (813) 290-6306
                              Email: tfarha@wellcarehmo.com

                  If to the Executive to:

                              Paul Behrens
                              ________________________________
                              ________________________________
                              Facsimile No.: _________________
                              Email: _________________________

All such notices, requests and other communications will (i) if delivered
personally to the address as provided in this Section 14, be deemed given upon
delivery, (ii) if delivered by facsimile transmission to the facsimile number as
provided for in this Section 14, be deemed given upon facsimile confirmation,
(iii) if delivered by email to the email address as provided for in this Section
14, be deemed given upon confirmation of receipt (provided that a copy is also
sent by first class United States mail as provided for in this Section 14) and
(iv) if delivered by overnight courier to the address as provided in this
Section 14, be deemed given on the earlier of the first business day following
the date sent by such overnight courier or upon receipt. Any party from time to
time may change its address, facsimile number or other information for the
purpose of notices to that party by giving notice specifying such change to the
other party hereto.

      15.   Entire Agreement; Modification. This Agreement constitutes the
entire agreement among the parties with respect to the subject matter hereof and
supersedes all prior agreements and understandings, both written and oral, among
the parties with respect to the subject matter hereof. This Agreement may be
amended or modified only by an instrument in writing duly executed by the
parties to this Agreement.

      16.   Waiver. Any term or condition of this Agreement may be waived at
any time by the party that is entitled to the benefit thereof, but no such
waiver shall be effective unless set forth in a written instrument duly executed
by or on behalf of the party waiving such term or condition. No waiver by any
party of any term or condition of this Agreement, in any one or more instances,
shall be deemed to be or construed as a waiver of the same or any other term or
condition of this Agreement on any future occasion. All remedies, either under
this Agreement or by law or otherwise afforded, will be cumulative and not
alternative.

      17.   No Assignment; Binding Effect. Neither this Agreement nor any right,
interest or obligation hereunder may be assigned (by operation of law or
otherwise) by any party without the prior written consent of the other party and
any attempt to do so will be void; provided, however, that the Company may, upon
notice to the Executive but without being obligated to

                                       11

<PAGE>

obtain the Executive's consent, assign this Agreement or any of its rights,
interests or obligations hereunder to an affiliate of the Company; provided,
further, that no such assignment shall relieve the Company of any of its
obligations hereunder. Subject to the preceding sentence, this Agreement is
binding upon, inures to the benefit of and is enforceable by the parties hereto
and their respective successors and assigns.

      18.   Survival. Notwithstanding anything to the contrary contained in this
Agreement, the provisions of Sections 5 through 25 of this Agreement shall
survive the termination or expiration, for any reason, of this Agreement.

      19.   Headings. The headings used in this Agreement have been inserted for
convenience of reference only and do not define or limit the provisions hereof.

      20.   Severability. Any term or provision of this Agreement that is
invalid, illegal or unenforceable in any situation in any jurisdiction shall not
affect the validity, legality or enforceability of the offending term or
provision in any other situation or in any other jurisdiction. If such
invalidity, illegality or unenforceability is caused by length of time or size
of area, or both, the otherwise invalid provision shall be, without further
action by the parties, automatically amended to such reduced period or area as
would cure such invalidity, illegality or unenforceability; provided, however,
that such amendment shall apply only with respect to the operation of such
provision in the particular jurisdiction in which such determinations is made.

      21.   Governing Law. This Agreement shall be governed by and construed in
accordance with the domestic laws of the State of Florida, without giving effect
to any choice of law or conflict of law provision or rule (whether of the State
of Florida or any other jurisdiction) that would cause the application of the
laws of any jurisdiction other than the State of Florida.

      22.   Jurisdiction; Venue. All actions and proceedings arising out of or
relating to this Agreement shall be heard and determined in any Florida state or
federal court sitting in the City of Tampa, Florida, and each party hereby
irrevocably accepts and consents to the exclusive personal jurisdiction of those
courts for such purpose. In addition, each party hereby irrevocably waives, to
the fullest extent permitted by law, any objection which it may now or hereafter
have to the laying of venue of any action or proceeding arising out of or
relating to this Agreement or any judgment entered by any court in respect
thereof brought in any state or federal court sitting in the city of Tampa,
Florida, and further irrevocably waives any claim that any action or proceeding
brought in any such court has been brought in an inconvenient forum.

      23.   Waiver of Trial by Jury. IN ANY ACTION OR PROCEEDING ARISING
HEREFROM, THE PARTIES HERETO CONSENT TO TRIAL WITHOUT A JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM BROUGHT BY ANY PARTY HERETO AGAINST THE OTHER OR
THEIR SUCCESSORS IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION WITH
THIS AGREEMENT, REGARDLESS OF THE FORM OF ACTION OR PROCEEDING.

      24.   Interpretation. The parties hereto agree that this Agreement is the
product of negotiation between sophisticated parties and individuals, all of
whom were represented by counsel, and each of whom had an opportunity to
participate in and did participate in, the

                                       12

<PAGE>

drafting of each provision hereof. Accordingly, ambiguities in this Agreement,
if any, shall not be construed strictly or in favor of or against any party
hereto but rather shall be given a fair and reasonable construction.

      25.   Counterparts. This Agreement may be executed in any number of
counterparts, each of which will be deemed an original, but all of which
together will constitute one and the same instrument.

                                   [SIGNATURE PAGE FOLLOWS]

                                       13

<PAGE>

      IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first written above.

                                    WELLCARE:

                                    WELLCARE HEALTH PLANS, INC.

                                    By /s/ Todd S. Farha
                                       -----------------------------------------
                                       Todd Farha
                                       President and Chief Executive Officer

                                    COMPANY:

                                    COMPREHENSIVE HEALTH
                                    MANAGEMENT, INC.

                                    By /s/ Todd S. Farha
                                       -----------------------------------------
                                       Todd Farha
                                       President and Chief Executive Officer

                                    EXECUTIVE:

                                    /s/ Paul Behrens
                                    --------------------------------------------
                                    Paul Behrens

                                       14<PAGE>
                                                                   Exhibit 10.30

                       PREPAYMENT AND AMENDMENT AGREEMENT

     This PREPAYMENT AND AMENDMENT AGREEMENT (this "AGREEMENT") is made and
entered into as of May 11, 2004, by and among WellCare Holdings, LLC, a Delaware
limited liability company ("PARENT"); WellCare Health Plans, Inc., a Delaware
corporation f/k/a WellCare Acquisition Company ("WELLCARE"); and Kiran C. Patel,
Pallavi Patel, Pradip C. Patel, Swati Patel, Rupesh Shah and Nita Shah (each, a
"STOCKHOLDER" and collectively, the "Stockholders"). Parent, WellCare and the
Stockholders are sometimes referred to in this Agreement individually as a
"PARTY" and collectively as the "PARTIES."

                                    RECITALS

     A. Parent, WellCare and the Stockholders are parties to that certain
Purchase Agreement, dated as of May 17, 2002 (as subsequently amended, the
"PURCHASE AGREEMENT"), pursuant to which WellCare acquired all of the
outstanding equity securities of Well Care HMO, Inc., a Florida corporation,
HealthEase of Florida, Inc., a Florida corporation, Comprehensive Health
Management, Inc., a Florida corporation, and Comprehensive Health Management of
Florida, L.C., a Florida limited liability company.

     B. On February 12, 2004, the Parties entered into that certain Amendment
and Settlement Agreement (the "SETTLEMENT AGREEMENT"), pursuant to which the
Parties settled certain disputes among them and amended the Purchase Agreement
and certain other documents related thereto.

     C. A portion of the purchase price under the Purchase Agreement was paid by
issuance of that certain Senior Subordinated Non-Negotiable Promissory Note
dated July 31, 2002, in the original principal amount of $53,000,000, issued by
WellCare to Kiran C. Patel, as Stockholder Representative on behalf of the
Stockholders (the "STOCKHOLDER REPRESENTATIVE"), as subsequently amended and
restated in its entirety by that certain Amended and Restated Senior
Subordinated Non-Negotiable Promissory Note dated February 12, 2004, in the
original principal amount of $116,240,692, issued by WellCare to the Stockholder
Representative (the "RESTATED NOTE").

     D. The obligations of WellCare under the Restated Note are secured by a
pledge of a portion of the capital stock of WellCare, as set forth in that
certain Pledge Agreement, dated as of July 31, 2002 (as subsequently amended,
the "PLEDGE AGREEMENT"), between Parent and the Stockholder Representative.

     E. The Parties now desire to provide for the prepayment of a portion of the
principal amount of the Restated Note and to otherwise amend the Restated Note
and the Pledge Agreement, and to provide for certain other matters, all as set
forth herein.

     NOW, THEREFORE, in consideration of the covenants and promises set forth
herein, and for other good and valuable consideration (the receipt and
sufficiency of which are hereby acknowledged), intending to be legally bound,
the Parties agree as follows:

     1. Definitions. Capitalized terms used and not defined herein shall have
the respective meanings ascribed to them in the Purchase Agreement.

                                       1
<PAGE>

     2. Prepayment; Forgiveness of Indebtedness.

          (a) On the Closing Date (as hereinafter defined), WellCare shall
prepay (without setoff for any reason) $85,000,000 of the outstanding principal
amount of the Restated Note (the "PREPAYMENT"), as follows:

               (i) $60,000,000 of the Prepayment shall be paid to the
Stockholder Representative, on behalf of the Stockholders; and

               (ii) the remaining $25,000,000 of the Prepayment (the "ESCROW
AMOUNT") shall be paid to Wachovia Bank, National Association ("WACHOVIA"), as
escrow agent (the "ESCROW AGENT"), to secure a portion of the indemnification
obligations of the Stockholders under the Purchase Agreement with respect to the
E.S. Thomas Claim and any E.S. Thomas Losses (as such terms are defined in the
Settlement Agreement), as set forth in that certain Escrow Agreement entered
into as of the date hereof among WellCare, the Stockholder Representative and
the Escrow Agent (the "ESCROW AGREEMENT").

The Parties acknowledge and agree that, notwithstanding anything to the contrary
in the Restated Note, the full amount of the Prepayment shall be credited to,
and shall reduce, the outstanding principal amount of the Restated Note in the
order of maturity.

          (b) Effective upon, and in consideration for, the Prepayment,
$3,000,000 of the outstanding principal amount of the Restated Note shall be
forgiven, and the outstanding principal amount of the Restated Note shall
automatically be reduced by such amount, resulting in a remaining outstanding
principal amount of $28,240,692 which shall be payable on September 15, 2006.

     3. Amendment of Restated Note. Effective upon the Closing Date, the
Restated Note shall be amended as follows:

          (a) The outstanding principal amount of the Restated Note shall be
Twenty Eight Million Two Hundred Forty Thousand Six Hundred and Ninety-Two
United States Dollars (U.S. $28,240,692).

          (b) The definition of "Qualified IPO" set forth in Sections 1(d) of
the Restated Note shall be deleted in its entirety.

          (c) Section 2 of the Restated Note shall be deleted in its entirety
and replaced with the following:

          "The principal amount hereunder shall be payable in full on the
Maturity Date."

          (d) Clause (i) of Section 8(a) of the Restated Note shall be deleted
in its entirety.

          (e) The parenthetical phrase "(subject to the Senior Debt Limit)" in
Section 8(k)(i) of the Restated Note shall be deleted.

                                       2
<PAGE>

          (f) The phrase "and the Maker's calculation of the applicable Senior
Debt Limit" and the parenthetical phrase "(provided that any payments of
dividends on account of any shares of its preferred stock shall lower the Senior
Debt Limit to the extent of such payments)" in Section 10 of the Restated Note
shall be deleted.

     4. Amendment of Pledge Agreement; Release of Pledged Shares.

          (a) Effective upon the Closing Date, the Pledge Agreement shall be
amended as follows:

               (i) All references in the Pledge Agreement to the "Note" shall be
deemed to refer to the Restated Note, as amended by Section 3 of this Agreement.

               (ii) The definition of "Pledged Shares" set forth in Section 1(b)
of the Pledge Agreement shall be deleted in its entirety and replaced with the
following:

               ""Pledged Shares" means 51% of the issued and outstanding capital
stock of Buyer."

               (iii) Subclause (c) contained in clause (ii) of Section 2(b) of
the Pledge Agreement shall be deleted.

               (iv) Section 2(e) of the Pledge Agreement shall be deleted in its
entirety.

               (v) Section 4(c) of the Pledge Agreement shall be deleted in its
entirety and replaced with the following:

               "Holdings shall cause Buyer to refrain from issuing to any person
     (other than Holdings) any shares of Buyer's capital stock or any other
     rights, options or warrants to acquire such stock, or any securities
     convertible into stock; provided, however, that Buyer may issue shares of
     stock and/or convertible securities so long as the Pledged Shares continue
     to represent the then-applicable requisite percentage of the issued and
     outstanding capital stock of Buyer set forth in the definition of "Pledged
     Shares.""

          (b) On the Closing Date, the Stockholder Representative shall execute
and deliver to WellCare an instruction letter, in the form attached hereto as
Exhibit A, to the Escrow Agent (as such term is defined in the Escrow Agreement,
dated as of July 31, 2002 (the "STOCK ESCROW AGREEMENT"), among the Parent, the
Stockholder Representative and National City Bank), directing the Escrow Agent
to release from escrow 49% of the Pledged Shares (as such term is defined in the
Pledge Agreement and in the Stock Escrow Agreement).

          (c) From and after the Closing Date, all references in the Stock
Escrow Agreement to the Pledge Agreement shall be deemed to refer to the Pledge
Agreement as amended hereby.

                                       3
<PAGE>

     5. Security. In the event that any Buyer Indemnified Party shall be
required to post a bond or similar arrangement in connection with the E.S.
Thomas Claim (as such term is defined in the Settlement Agreement), including,
without limitation, any bond required to be posted in connection with any appeal
that any Buyer Indemnified Party may determine to undertake with respect to any
ruling, judgment or other decree or binding statement of any court regarding,
related to or in connection with the E.S. Thomas Claim, the Stockholder
Representative shall fully fund the Stockholders' collective pro-rata portion of
such bond or other arrangement, calculated based upon the proportion of the
total amount of E.S. Thomas Losses for which the Stockholders are responsible
under the Purchase Agreement. Such funding may be provided in the form of cash
(including the amount then being held in escrow pursuant to the terms of the
Escrow Agreement) and/or such other collateral as may be acceptable to the
applicable bonding company or similar type entity. By way of example, in the
event that a bonding company were to require the deposit of collateral in the
amount of 125% of a judgment, the Stockholders would be required to provide
appropriate collateral for 125% of the portion of such judgment with respect to
which the Buyer Indemnified Parties would be entitled to recover from the
Stockholders pursuant to the terms of the Purchase Agreement (disregarding, for
this purpose only, any defenses the Stockholders may have to their
indemnification obligations under the Purchase Agreement). The Stockholders
shall, as of the Closing Date, cause any and all pledges and other Liens on the
Stockholders' interests in the Restated Note in excess of $10,000,000 to be
terminated and extinguished, and thereafter shall not pledge or otherwise permit
the imposition of any Liens on the Restated Note in excess of $10,000,000
without the prior written consent of WellCare, which consent may be granted or
denied in WellCare's sole discretion.

     6. Closing; Termination. The closing of the transactions described herein
(the "CLOSING") shall occur on a date (the "CLOSING DATE") to be selected by
WellCare; provided that WellCare's obligation to consummate the transactions
contemplated herein is conditioned on WellCare's receipt of gross proceeds of
not less than $100,000,000 pursuant to a secured debt financing (the "QUALIFIED
FINANCING"). On the Closing Date, (a) WellCare shall make the Prepayment, and
(b) the Stockholder Representative shall execute and deliver to WellCare the
instruction letter referred to in Section 4(b) hereof. Either WellCare or the
Stockholder Representative (on behalf of the Stockholders) may terminate this
Agreement upon written notice to the other if the Closing shall not have
occurred by July 31, 2004, in which case this Agreement shall become void and of
no further force or effect.

     7. Representations and Warranties.

          (a) Each of the Stockholders hereby represents and warrants to
WellCare that (i) such Stockholder is under no obligation or restriction that
would in any way interfere or conflict with his or her performance hereunder,
and (ii) the execution and delivery of this Agreement and/or, if applicable, the
Escrow Agreement by such Stockholder will not result in a violation or breach
of, or constitute (with or without the giving of notice or lapse of time or
both) a default (or give rise to any right of termination, cancellation, payment
or acceleration) under, any Credit Agreement, note or any other contract or
agreement between any lender or any other Person, including Bank of America,
N.A., and any Stockholder.

          (b) Each of Parent and WellCare hereby represents and warrants to each
Stockholder that (i) subject to the satisfaction of the condition set forth in
Section 6 hereof, such

                                       4
<PAGE>

Party is under no obligation or restriction that would in any way interfere or
conflict with its performance hereunder, and (ii) subject to the receipt of
consents from Bank of America and GSC Partners, the execution and delivery of
this Agreement and/or the Escrow Agreement by such Party will not result in a
violation or breach of, or constitute (with or without the giving of notice or
lapse of time or both) a default (or give rise to any right of termination,
cancellation, payment or acceleration) under, any Credit Agreement, note or any
other contract or agreement between any lender or any other Person.

     8. Confidentiality. Each of the Parties hereby agrees to keep the terms of
this Agreement confidential; provided, however, that the foregoing shall not
prevent or restrict any disclosure (a) to such Party's professional advisors,
financing sources or prospective financing sources, (b) which is required by
order of court or Governmental or Regulatory Authority with subpoena powers
(provided that the Party subject thereto shall have provided the other Parties
with prior notice of such order and an opportunity to object or seek a
protective order and take any other available action), (c) in the course of any
Action or Proceeding between any of the Parties hereto or (d) by WellCare or any
of its affiliates to the extent required or desirable under applicable Law or
the rules of any stock exchange.

     9. Entire Agreement; Modification. This Agreement and the Exhibits hereto
constitute the entire agreement among the parties with respect to the subject
matter hereof and supersede all prior agreements and understandings, both
written and oral, among the parties with respect to the subject matter hereof.
This Agreement may be amended or modified only by an instrument in writing duly
executed by the Parties.

     10. Pledge Agreement, Restated Note, and Settlement Agreement Effective.
Except as otherwise specifically set forth in this Agreement, all provisions of
the Pledge Agreement and the Restated Note (including the calculation of
interest as provided therein) which are not in conflict with the terms of this
Agreement shall remain in full force and effect. The Settlement Agreement
remains in full force and effect. Without limiting the generality of the
previous sentence, the provisions of the Settlement Agreement relating to the
Buyer Indemnification Threshold, the Seller Indemnification Threshold, the Buyer
Indemnification Cap and the Stockholder Indemnification Cap are in full force
and effect and are not impacted in any manner by this Agreement or the Escrow
Agreement.

     11. Purchase Agreement. Section 9.2(f) of the Purchase Agreement as well as
any other applicable provision of the Purchase Agreement, the Restated Note and
the Settlement Agreement are hereby amended to the extent necessary to provide
that cash and any other assets held in escrow pursuant to the Escrow Agreement
are a permissible source of recovery for any Buyer Indemnified Party with
respect to the E.S. Thomas Claim and any E.S. Thomas Losses.

     12. Bank of America as Replacement Escrow Agent. If at any time during the
60-day period beginning on the day immediately following the Closing Date, (i)
Bank of America, N.A. ("BoA") is willing to enter into an escrow agreement
identical to the Escrow Agreement (except for the change of the escrow agent
from Wachovia to BoA), as reasonably determined by WellCare (such an escrow
agreement, an "IDENTICAL ESCROW AGREEMENT"), and (ii) the Stockholder
Representative desires that BoA replace Wachovia as the escrow agent under the
Escrow Agreement (in each case, which shall be evidenced by the Stockholder
Representative

                                       5
<PAGE>

sending a written notice to WellCare stating such desire by the Stockholder
Representative along with a signed letter from BoA stating that BoA is willing
to enter into an Identical Escrow Agreement), then WellCare shall join with the
Stockholder Representative (A) to take reasonably appropriate actions to sign
such an Identical Escrow Agreement with BoA and (B) to move all property then in
the escrow account established with Wachovia pursuant to the Escrow Agreement to
the escrow account established with BoA pursuant to the Identical Escrow
Agreement. Notwithstanding anything contained herein to the contrary (I) all
costs of entering into an Identical Escrow Agreement shall be borne solely by
the Stockholder Representative, (II) WellCare shall have no obligations to enter
into any escrow agreement with the Stockholder Agreement and BoA other than an
Identical Escrow Agreement as expressly provided herein and (III) WellCare shall
have no obligation to convince or influence BoA to enter into an Identical
Escrow Agreement or to establish an escrow account pursuant thereto.

     13. Waiver. Any term or condition of this Agreement may be waived at any
time by the Party that is entitled to the benefit thereof, but no such waiver
shall be effective unless set forth in a written instrument duly executed by or
on behalf of the Party waiving such term or condition. No waiver by any Party of
any term or condition of this Agreement, in any one or more instances, shall be
deemed to be or construed as a waiver of the same or any other term or condition
of this Agreement on any future occasion. All remedies, either under this
Agreement or by Law or otherwise afforded, will be cumulative and not
alternative.

     14. Binding Effect. This Agreement is binding upon, inures to the benefit
of and is enforceable by the Parties and their respective successors and
assigns. The Stockholders acknowledge that WellCare Group, Inc., a Subsidiary of
Parent ("WCG"), has filed a registration statement under the Securities Act in
connection with a proposed initial public offering of the common stock of WCG
and that, subject to the consummation of such offering, it is expected that
Parent will be merged with and into WCG, in which case all references to Parent
in this Agreement, the Settlement Agreement, the Purchase Agreement and any
Ancillary Agreements shall be deemed to be references to WCG, as
successor-in-interest to Parent.

     15. Headings. The headings used in this Agreement have been inserted for
convenience of reference only and do not define or limit the provisions hereof.

     16. Invalid Provisions. If any provision of this Agreement is held to be
illegal, invalid or unenforceable under any present or future Law, and if the
rights or obligations of any Party under this Agreement will not be materially
and adversely affected thereby, (a) such provision will be fully severable, (b)
this Agreement will be construed and enforced as if such illegal, invalid or
unenforceable provision had never comprised a part hereof, (c) the remaining
provisions of this Agreement will remain in full force and effect and will not
be affected by the illegal, invalid or unenforceable provision or by its
severance herefrom and (d) in lieu of such illegal, invalid or unenforceable
provision, there will be added automatically as a part of this Agreement a
legal, valid and enforceable provision as similar in terms to such illegal,
invalid or unenforceable provision as may be possible.

     17. Governing Law. This Agreement shall be governed by and construed in
accordance with the domestic laws of the State of New York, without giving
effect to any choice of law or conflict of law provision or rule (whether of the
State of New York

                                       6
<PAGE>

or any other jurisdiction) that would cause the application of the laws of any
jurisdiction other than the State of New York.

     18. Jurisdiction; Venue. All actions and proceedings arising out of or
relating to this Agreement shall be heard and determined in any Florida state or
federal court sitting in the City of Tampa, Florida, and each Party hereby
irrevocably accepts and consents to the exclusive personal jurisdiction of those
courts for such purpose. In addition, each Party hereby irrevocably waives, to
the fullest extent permitted by law, any objection which it may now or hereafter
have to the laying of venue of any action or proceeding arising out of or
relating to this Agreement or any judgment entered by any court in respect
thereof brought in any state or federal court sitting in the city of Tampa,
Florida and further irrevocably waives any claim that any action or proceeding
brought in any such court has been brought in an inconvenient forum.

     19. Waiver of Jury Trial. IN ANY ACTION OR PROCEEDING ARISING HEREFROM, THE
PARTIES HERETO CONSENT TO TRIAL WITHOUT A JURY IN ANY ACTION, PROCEEDING OR
COUNTERCLAIM BROUGHT BY ANY PARTY HERETO AGAINST THE OTHER OR THEIR SUCCESSORS
IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT,
REGARDLESS OF THE FORM OF ACTION OR PROCEEDING.

     20. Counterparts. This Agreement may be executed in any number of
counterparts, each of which will be deemed an original, but all of which
together will constitute one and the same instrument.

                            [SIGNATURE PAGE FOLLOWS]

                                       7
<PAGE>

        IN WITNESS WHEREOF, the parties hereto have executed this Prepayment and
Amendment Agreement as of the date first above written.

  <Table>
  <Caption>
  WellCare Health Plans, Inc.                    WellCare Holdings, LLC

<S>                                             <C>
  By:   /s/ Todd S. Farha                        By: /s/ Todd S. Farha
       ---------------------------------------      ------------------
       Name:    Todd S. Farha                          Name:    Todd S. Farha
       Title:  President & Chief Executive             Title:  President & Chief Executive
                Officer                                          Officer
  </Table>

  <Table>
  <Caption>
                                  STOCKHOLDERS

<S>                                             <C>
   /s/ Kiran C. Patel                             /s/ Pallavi Patel
  --------------------------------------------   ------------------
        Kiran C. Patel                                 Pallavi Patel

   /s/ Pradip C. Patel                            /s/ Swati Patel
  --------------------------------------------   ----------------
        Pradip C. Patel                                Swati Patel

   /s/ Rupesh Shah                                /s/ Nita Shah
  --------------------------------------------   ----------------
        Rupesh Shah                                    Nita Shah
  </Table>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}]]